Neurocrine Biosciences, Inc. (NBIX)
163.21
-0.67
(-0.41%)
USD |
NASDAQ |
Jun 08, 16:00
163.21
0.00 (0.00%)
After-Hours: 19:29
Neurocrine Biosciences Shareholders Equity (Quarterly) : 3.407B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Amgen, Inc. | 9.19B |
| Iovance Biotherapeutics, Inc. | 721.75M |
| Voyager Therapeutics, Inc. | 173.67M |
| Incyte Corp. | 5.623B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.906B |
| Total Liabilities (Quarterly) | 1.499B |
| Debt to Equity Ratio | 0.1192 |
| Current Ratio | 2.929 |
| Net Debt Paydown Yield | 0.14% |